Particle.news
Drug Development Clinical Trials Vaccine Development Clinical Research Drug Discovery Drug Delivery Systems Antibiotics Antibody Development Drug Combinations Drug Companies Research and Development AVEO Pharmaceuticals Acquisition Antibody Therapeutics Drug Formulation Cancer Research Genetic Research Moderna Drug Candidates AI Applications Takeda Pharmaceutical Company AI Models Research Security Diagnostics Investment Strategies Veterinary Applications Vaccine Technology Vaccine Innovation Oncology Protein Delivery Systems Monoclonal Antibodies Fertility Drugs Antibiotic Resistance Manufacturing Research Programs Biosanitary Applications Polilaminina Cancer Vaccines Weight Loss Drugs Antibiotic Development
Releasing three synergistic drugs directly at tumor sites, the implant bypasses the blood‑brain barrier and points to a path for clinical translation.
